1. Bouquet de Jolinière, J., Validire, P., Canis, M., Doussau, M., Levardon, M., and Gogusev, J., Human endometriosis-derived permanent cell line (FbEM-1): establishment and characterization, Hum. Reprod. Update, 1997, vol. 3, pp. 117–4.
2. Brinton, L.A., Gridley, G., Persson, I., Baron, J., and Bergqvist, A., Cancer risk after a hospital discharge diagnosis of endometriosis, Am. J. Obstetrics Gynecol., 1997, vol. 176, pp. 572–4.
3. Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Halling, K.C., Keeney, G., Podratz, K.C., and Jenkins, R.B., Human epithelial ovarian cancer allelotype, Cancer Res., 1993, vol. 53, pp. 2393–4.
4. De Hondt, A., Peeraer, K., Meuleman, C., Meeuwis, L., De Loecker, P., and D’Hooghe, T.M., Endometriosis and subfertility treatment: a review, Minerva Ginecol., 2005, vol. 57, pp. 257–4.
5. Domnina, A.P., Fridlyanskaia, I.I., Zemelko, V.I., Pugovkina, N.A., Kovaleva, Z.V., Zenin, V.V., Grinchuk, T.M., and Nikolsky, N.N., Mesenchymal stem cells of human endometrium do not undergo spontaneous transformation during long-term cultivation, Cell Tissue Biol., 2013, vol. 55, pp. 69–4.